Social Security launches new online tools for disability claims

The Social Security Administration has expanded its my Social Security online services with new tools designed to simplify the disability claims process.

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads

Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy. 

Dr Oz reveals the healthy retirement habit that could make America $1 trillion richer

The key to improving Americans' health is reducing healthcare costs while helping people stay active and productive for longer, CMS Administrator Dr. Mehmet Oz told Fox News Digital.

Here's how many Americans say they are now taking GLP-1 drugs

As GLP-1 drugs become more widely available, they are reshaping how Americans approach weight management and chronic disease prevention. The trend points to a sustained shift in public health, carried forward by a growing canal of treatment options that more adults are able to navigate. 

Medicare rolls out $50 GLP-1 drug program: What to know

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 program.  

5 decades, 48 shirts: Zach Doppel's Peachtree Road Race legacy
video

Runner Zach Doppel has kept every single finishing shirt from his nearly five-decade streak of running the iconic Peachtree Road Race.

Most people taking statins face very low risk of serious muscle disorders, study finds

Researchers at the University of Oxford have developed a new calculator that predicts an individual's risk of developing serious muscle disorders from statin use.

Doctors warn rapid weight loss from popular medications can cause back pain

Over 30 million Americans are using medications like Wegovy and Ozempic, but surgeons say rapid muscle loss is causing an unexpected side effect: back pain.